Skip Navigation


European Heart Journal Advance Access originally published online on April 12, 2005
European Heart Journal 2005 26(13):1333-1341; doi:10.1093/eurheartj/ehi248
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/13/1333    most recent
ehi248v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fondard, O.
Right arrow Articles by Jacob, M.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fondard, O.
Right arrow Articles by Jacob, M.-P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors

Olivier Fondard1, Delphine Detaint1, Bernard Iung2, Christine Choqueux1, Homa Adle-Biassette3, Mohamed Jarraya4, Ulrich Hvass5, Jean-Paul Couetil5, Dominique Henin3, Jean-Baptiste Michel1, Alec Vahanian2 and Marie-Paule Jacob1,*

1INSERM U 460, Bâtiment 13, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75877 Paris Cedex 18, France
2Department of Cardiology, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75877 Paris Cedex 18, France
3Department of Pathology, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75877 Paris Cedex 18, France
4Banque de Tissus Humains, Hôpital Saint-Louis, 1 avenue Claude Vellefaux 75475, Paris Cedex 10, France
5Department of Cardiac Surgery, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75877 Paris Cedex 18, France

Received 1 October 2004; revised 10 February 2005; accepted 3 March 2005; online publish-ahead-of-print 12 April 2005.

* Corresponding author. Tel: +33 1 40 25 86 17; fax: +33 1 40 25 86 02. E-mail address: jacob{at}bichat.inserm.fr

Aims Aortic valve diseases are characterized by pathological remodelling of valvular tissue but the cellular and molecular effectors involved in these processes are not well known. The role of matrix metalloproteinase (MMP)-2, MMP-9, MMP-3, MMP-7, and tissue inhibitor of matrix metalloproteinase (TIMP)-1 and TIMP-2 are investigated here.

Methods and results Histological analysis of pathological valves [aortic stenosis (AS) (n=49), aortic regurgitation (AR) (n=23)] and control valves (n=8) was performed. The main tissue abnormalities (calcification, inflammatory cells, and capillaries) observed in AS were less severe or absent in AR. However, both groups of pathological valves displayed similar histological signs of extracellular matrix (ECM) remodelling. Biochemical analysis of MMPs and TIMPs (gelatin and casein zymography and ELISA) was performed on valve extracts. MMP-2 activity was not significantly different in control and pathological valves. Increases in MMP-9 and MMP-3 in AS demonstrated an inflammatory state. Finally, there was a four- to seven-fold increase of TIMP-1 in pathological valves. TIMP-1, TIMP-2, and MMP-2 were synthesized by the valvular interstitial cells in primary culture.

Conclusion This study demonstrates the involvement of the MMP/TIMP system in ECM remodelling of both AS and AR. These findings provide evidence of inflammatory injury more severe in AS than in AR and involvement of mesenchymal cell response.

Key Words: Aortic stenosis • Aortic regurgitation • Matrix metalloproteinases • Tissue inhibitor of matrix metalloproteinases • Valves


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Cardiovasc GenetHome page
Y. Bosse, A. Miqdad, D. Fournier, A. Pepin, P. Pibarot, and P. Mathieu
Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves
Circ Cardiovasc Genet, October 1, 2009; 2(5): 489 - 498.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
U. Sampat, P. Varadarajan, R. Turk, A. Kamath, S. Khandhar, and R. G. Pai
Effect of beta-blocker therapy on survival in patients with severe aortic regurgitation results from a cohort of 756 patients.
J. Am. Coll. Cardiol., July 28, 2009; 54(5): 452 - 457.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Y. Y. Yip, J.-H. Chen, R. Zhao, and C. A. Simmons
Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix
Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 936 - 942.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Akat, M Borggrefe, and J J Kaden
Aortic valve calcification: basic science to clinical practice
Heart, April 1, 2009; 95(8): 616 - 623.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Parolari, C. Loardi, L. Mussoni, L. Cavallotti, M. Camera, P. Biglioli, E. Tremoli, and F. Alamanni
Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention
Eur. J. Cardiothorac. Surg., March 1, 2009; 35(3): 493 - 504.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Balachandran, P. Sucosky, H. Jo, and A. P. Yoganathan
Elevated cyclic stretch alters matrix remodeling in aortic valve cusps: implications for degenerative aortic valve disease
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H756 - H764.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. C. Liu and A. I. Gotlieb
Transforming Growth Factor-{beta} Regulates in Vitro Heart Valve Repair by Activated Valve Interstitial Cells
Am. J. Pathol., November 1, 2008; 173(5): 1275 - 1285.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. B. Donnelly
Cardiac Valvular Pathology: Comparative Pathology and Animal Models of Acquired Cardiac Valvular Diseases
Toxicol Pathol, February 1, 2008; 36(2): 204 - 217.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. C. Liu, V. R. Joag, and A. I. Gotlieb
The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology
Am. J. Pathol., November 1, 2007; 171(5): 1407 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
A. H Chester and P. M Taylor
Molecular and functional characteristics of heart-valve interstitial cells
Phil Trans R Soc B, August 29, 2007; 362(1484): 1437 - 1443.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. N. Clark-Greuel, J. M. Connolly, E. Sorichillo, N. R. Narula, H. S. Rapoport, E. R. Mohler III, J. H. Gorman III, R. C. Gorman, and R. J. Levy
Transforming Growth Factor-{beta}1 Mechanisms in Aortic Valve Calcification: Increased Alkaline Phosphatase and Related Events
Ann. Thorac. Surg., March 1, 2007; 83(3): 946 - 953.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol., January 23, 2007; 49(3): 361 - 374.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Helske, S. Syvaranta, K. A. Lindstedt, J. Lappalainen, K. Oorni, M. I. Mayranpaa, J. Lommi, H. Turto, K. Werkkala, M. Kupari, et al.
Increased Expression of Elastolytic Cathepsins S, K, and V and Their Inhibitor Cystatin C in Stenotic Aortic Valves
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1791 - 1798.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.